Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative S-ketamine for post-cesarean pain
ChiCTR2300078310Phase 4Not yet recruiting
- Sponsor
- Fuling Central Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postoperative pain (2 arms), sponsored by Fuling Central Hospital. Primary endpoint: Maximum pain numeric rating scale score at 24 hours postoperatively. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300078310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078310.